Roivant Sciences (ROIV) PT Raised to $46 at Guggenheim
Tweet Send to a Friend
Guggenheim analyst Yastin Suneja raised the price target on Roivant Sciences (NASDAQ: ROIV) to $46.00 (from $42.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
